Koyfin Home > Directory > Health Care > Alder Biopharma > EV / Sales (ntm)

Alder Biopharma EV / Sales (ntm) Chart (ALDR)

Alder Biopharma annual/quarterly EV / Sales (ntm) from 2014 to 2019.
  • Alder Biopharma EV / Sales (ntm) for the quarter ending October 10, 2019 was 166.55 a 0.06% increase of 0.09 year over year
  • Alder Biopharma EV / Sales (ntm) for the last 12 months ending October 10, 2019 was 166.55 a 0.06% increase of 0.09 year over year
  • Alder Biopharma Annual EV / Sales (ntm) for 2019 was 166.55 a -0.23% decrease of -0.38 from 2018
  • Alder Biopharma Annual EV / Sales (ntm) for 2019 was 166.93 a 0.11% increase of 0.19 from 2018
  • Alder Biopharma Annual EV / Sales (ntm) for 2019 was 166.74 a 0.17% increase of 0.28 from 2018
Other Valuation Metrics:
  • Alder Biopharma Market Cap for the quarter ending March 03, 2018 was $862m a 33.01% increase of 284m year over year
  • Alder Biopharma Price / Book for the quarter ending March 03, 2018 was 3.09 a 34.98% increase of 1.08 year over year
  • Alder Biopharma Enterprise Value for the quarter ending March 03, 2018 was $585m a 50.86% increase of 298m year over year
View Chart On Koyfin

Quarterly ALDR EV / Sales (ntm) Data

10/2019166.55
10/2019166.93
10/2019166.74
10/2019166.45
10/2019166.55
10/2019166.93
10/2019166.45
10/2019166.55
10/2019167.02
10/2019166.36

Annual ALDR EV / Sales (ntm) Data

2019166.55
2019166.93
2019166.74
2019166.45
2019166.55
2019166.93
2019166.45
2019166.55
2019167.02
2019166.36